WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Axsome Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark L. JacobsonChief Operating Officer2026-02-2635,378$161.88
$5.73MSell
Mark ColemanDirector2026-02-2625,000$161.11
$4.03MSell
Mark L. JacobsonChief Operating Officer2026-02-2635,378$2.85
$100.83kBuy
Mark ColemanDirector2026-02-236,250$4.95
$30.94kBuy
Mark ColemanDirector2026-02-2012,485$4.95
$61.80kBuy
Mark ColemanDirector2026-02-105,193$8.02
$41.65kBuy
Herriot TabuteauChief Executive Officer2026-02-0232,410$185.60
$6.02MSell
Herriot TabuteauChief Executive Officer2026-02-0232,410$8.02
$259.93kBuy
Nick PizzieChief Financial Officer2026-01-2212,000$3.50
$42.00kBuy
Nick PizzieChief Financial Officer2026-01-2212,000$187.92
$2.26MSell

1 of 9

AXSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AXSM insiders and whales buy or sell their stock.

AXSM Shareholders

What type of owners hold Axsome Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Herriot Tabuteau28.73%14,696,229$2.62BInsider
Antecip Capital LLC14.36%7,344,500$1.31BInsider
Vanguard Group Inc8.14%4,164,818$741.80MInstitution
Blackrock Inc7.65%3,913,543$697.04MInstitution
Price T Rowe Associates Inc2.95%1,509,870$268.92MInstitution
Invesco Ltd2.49%1,273,494$226.82MInstitution
Wellington Management Group LLP2.39%1,221,656$217.59MInstitution
Fmr LLC2.31%1,181,622$210.46MInstitution
Deep Track Capital LP2.25%1,150,000$204.83MInstitution
Geode Capital Management LLC1.97%1,010,249$179.94MInstitution

1 of 3

AXSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AXSM62.01%37.99%Net SellingNet Selling
ARWR82.92%9.84%Net SellingNet Selling
PRAX67.65%32.35%Net Selling
PCVX88.01%11.99%Net SellingNet Selling
TECH97.79%2.21%Net BuyingNet Selling
View Top Biotech Stocks

Axsome Therapeutics Stock Ownership FAQ

Who owns Axsome Therapeutics?

Axsome Therapeutics (NASDAQ: AXSM) is owned by 73.58% institutional shareholders, 45.09% Axsome Therapeutics insiders, and 0.00% retail investors. Herriot Tabuteau is the largest individual Axsome Therapeutics shareholder, owning 14.70M shares representing 28.73% of the company. Herriot Tabuteau's Axsome Therapeutics shares are currently valued at $2.62B.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.